We are live on ! Find out more
TGTX icon

TG Therapeutics
TGTX

51 hedge funds and large institutions have $80.2M invested in TG Therapeutics in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

693% more call options, than puts

Call options by funds: $1.74M | Put options by funds: $219K

190% more capital invested

Capital invested by funds: $27.7M → $80.2M (+$52.5M)

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

130% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 10

13% more funds holding

Funds holding: 45 → 51 (+6)

Holders
51
Holders Change
+6
Holders Change %
+13.33%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
23
Reduced
10
Closed
4
Calls
$1.74M
Puts
$219K
Net Calls
+$1.52M
Net Calls Change
+$1.54M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$16.7M
2
BM
Bridger Management
New York
+$5.33M
3
SFM
Sphera Funds Management
Israel
+$1.18M
4
TC
TFS Capital
Pennsylvania
+$1.06M
5
Morgan Stanley
Morgan Stanley
New York
+$650K

Top Sellers

Rank Fund Capital Flow
1
DCM
DAFNA Capital Management
California
-$293K
2
SM
Sabby Management
Florida
-$257K
3
BBA
Baker Bros. Advisors
New York
-$229K
4
Deutsche Bank
Deutsche Bank
Germany
-$140K
5
Two Sigma Investments
Two Sigma Investments
New York
-$46K
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$226K +$29K +4,900 +18%
Deutsche Bank
27
Deutsche Bank
Germany
$202K -$140K -23,570 -44%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$187K +$57.4K +9,697 +56%
TA
29
Teachers Advisors
New York
$147K – – –
JC
30
JBF Capital
Colorado
$115K +$98.7K +16,676 New
ProShare Advisors
31
ProShare Advisors
Maryland
$109K +$93.1K +15,738 New
BRWA
32
B. Riley Wealth Advisors
Florida
$92K +$79K +13,347 New
NFA
33
Nationwide Fund Advisors
Ohio
$90K +$4.87K +822 +7%
Bank of Montreal
34
Bank of Montreal
Ontario, Canada
$75K +$63.9K +10,800 New
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$73K -$3.67K -620 -6%
AIG
36
American International Group
New York
$72.9K +$1.5K +254 +2%
BA
37
BlackRock Advisors
Delaware
$66K +$12.5K +2,114 +28%
PCM
38
Prelude Capital Management
New York
$62K +$53.3K +9,005 New
U
39
UBS
Switzerland
$40K +$22.1K +3,733 +177%
SO
40
STRS Ohio
Ohio
$37K – – –
Citigroup
41
Citigroup
New York
$20K -$13.8K -2,327 -44%
LTFS
42
Ladenburg Thalmann Financial Services
Florida
$19K +$7.38K +1,247 +80%
TRCT
43
Tower Research Capital (TRC)
New York
$15K +$12.8K +2,170 New
TDC
44
Thompson Davis & Co
Virginia
$4K -$2.96K -500 -50%
Barclays
45
Barclays
United Kingdom
$4K +$2K +337 +98%
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$3.19K -$983 -166 -22%
Janus Henderson Group
47
Janus Henderson Group
United Kingdom
$2K – – –
AllianceBernstein
48
AllianceBernstein
Tennessee
$1K -$2.37K -400 -83%
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$55 – – –
DCM
50
DAFNA Capital Management
California
– -$293K -75,000 Closed
1
2
3

TGTX Hedge Fund Activity: Q1 2014 in Review

51 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in TG Therapeutics (TGTX) for Q1 2014, worth a combined $80.2M — up 190% from $27.7M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new TGTX positions and 4 closed out — a net gain of 6 holders — while 23 added to existing stakes and 10 trimmed.

The largest buyer was JP Morgan Chase, opening a new position worth an estimated $16.7M. The largest seller was DAFNA Capital Management, exiting entirely with an estimated $293K sold.

  • 51 institutional investors held TG Therapeutics (TGTX) as of Q1 2014, up from 45 in Q4 2013.
  • Funds reported $80.2M of TG Therapeutics stock for Q1 2014, up 190% quarter-over-quarter.
  • 10 funds opened new TG Therapeutics positions in Q1 2014 and 4 closed out, a net change of +6 holders.
  • The largest TG Therapeutics buyer in Q1 2014 was JP Morgan Chase, an estimated $16.7M added.
  • The largest TG Therapeutics seller in Q1 2014 was DAFNA Capital Management, an estimated $293K sold.

Based on aggregated 13F filings for Q1 2014.